Drugs@FDA document
BICILLIN C-R Letter · NDA 050138 SUPPL-239
Drugs@FDA document · KING PHARMS LLC · Nov 15, 2018
Key facts
| Drug name | BICILLIN C-R |
|---|---|
| Document type | Letter |
| Application | NDA050138 |
| Submission | SUPPL-239 |
| Company | KING PHARMS LLC |
| Document date | Nov 15, 2018 |
| FDA document | accessdata.fda.gov |
At a glance
- Labeling-Package Insert Document categories
- 10–99 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: